Circulating microRNAs and Kallikreins before and after radical prostatectomy: Are they really prostate cancer markers?

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Egidi, Maria Giulia ^a   Cochetti, Giovanni ^a   Serva, Maria Rita ^a   Guelfi, Gabriella ^a   Zampini, Danilo ^a   Mechelli, Luca ^a   Mearini, Ettore ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HK11; HK13; HK3; KALLIKREIN; MICRORNA 141; MICRORNA 21; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; KLK13 PROTEIN, HUMAN; MICRORNA; MIRN141 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; SERINE PROTEINASE; TRYPSIN LIKE SERINE PROTEASE; TRYPSIN-LIKE SERINE PROTEASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; POSTOPERATIVE PERIOD; PROSTATE CANCER; PROSTATECTOMY; REAL TIME POLYMERASE CHAIN REACTION; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; MIDDLE AGED; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DEMOGRAPHY; HUMANS; KALLIKREINS; MALE; MICRORNAS; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84887499543     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/241780     Document Type: Article

References (47)

1. Diamandis E. P., Yousef G. M., Soosaipillai A. R., Bunting P., Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clinical Biochemistry 2000 33 7 579 583 2-s2.0-0034543474 10.1016/S0009-9120(00)00182-X
2. Obiezu C. V., Scorilas A., Katsaros D., Massobrio M., Yousef G. M., Fracchioli S., Rigault de la Longrais I. A., Arisio R., Diamandis E. P., Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clinical Cancer Research 2001 7 8 2380 2386 2-s2.0-0034881126
3. Yousef G. M., Scorilas A., Jung K., Ashworth L. K., Diamandis E. P., Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. Journal of Biological Chemistry 2001 276 1 53 61 2-s2.0-0035808428 10.1074/jbc.M005432200
4. Bartel D. P., microRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5
5. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 1 15 20 2-s2.0-11844278458 10.1016/j.cell.2004.12.035
6. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 2-s2.0-48749122914 10.1073/pnas.0804549105
7. Calin G. A., Sevignani C., Dumitru C. D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C. M., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 2999 3004 2-s2.0-12144290519 10.1073/pnas.0307323101
8. Porkka K. P., Pfeiffer M. J., Waltering K. K., Vessella R. L., Tammela T. L. J., Visakorpi T., MicroRNA expression profiling in prostate cancer. Cancer Research 2007 67 13 6130 6135 2-s2.0-34447132924 10.1158/0008-5472.CAN-07-0533
9. Profiling of microRNA in serum/plasma and other biofluids-Guidelines for the miRCURY LNATM Universal RT microRNA PCR System, 3rd edition. http://www.exiqon.com/
10. Mearini E., Cottini E., Cochetti G., Antognelli C., Talesa V., Biomarkers of prostate cancer. A review. Minerva Urologica e Nefrologica 2010 62 2 163 178 2-s2.0-77957709230
11. Diamandis E. P., Yousef G. M., Human tissue kallikreins: a family of new cancer biomarkers. Clinical Chemistry 2002 48 8 1198 1205 2-s2.0-0036320526
12. Sotiropoulou G., Rogakos V., Tsetsenis T., Pampalakis G., Zafiropoulos N., Simillides G., Yiotakis A., Diamandis E. P., Emerging interest in the Kallikrein gene family for understanding and diagnosing cancer. Oncology Research 2002 13 6-10 381 391 2-s2.0-0842284095
13. Michael I. P., Pampalakis G., Mikolajczyk S. D., Malm J., Sotiropoulou G., Diamandis E. P., Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. Journal of Biological Chemistry 2006 281 18 12743 12750 2-s2.0-33744962676 10.1074/jbc.M600326200
14. Becker C., Piironen T., Pettersson K., Björk T., Wojno K. J., Oesterling J. E., Lilja H., Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum. Journal of Urology 2000 163 1 311 316 2-s2.0-0033992278
15. Vickers A. J., Cronin A. M., Aus G., Pihl C., Becker C., Pettersson K., Scardino P. T., Hugosson J., Lilja H., A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden. BMC Medicine 2008 6 19 2-s2.0-48249152185 10.1186/1741-7015-6-19
16. Bi X., He H., Ye Y., Dai Q., Han Z., Liang Y., Zhong W., Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Medical Oncology 2010 27 1 145 151 2-s2.0-77949266077 10.1007/s12032-009-9185-0
17. Chang A., Yousef G. M., Scorilas A., Grass L., Sismondi P., Ponzone R., Diamandis E. P., Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. British Journal of Cancer 2002 86 9 1457 1464 2-s2.0-0037029685 10.1038/sj.bjc.6600283
18. Nelson K. M., Weiss G. J., microRNAs and cancer: past, present, and potential future. Molecular Cancer Therapeutics 2008 7 12 3655 3660 2-s2.0-57749086300 10.1158/1535-7163.MCT-08-0586
19. Catto J. W. F., Alcaraz A., Bjartell A. S., De Vere White R., Evans C. P., Fussel S., Hamdy F. C., Kallioniemi O., Mengual L., Schlomm T., Visakorpi T., MicroRNA in prostate, bladder, and kidney cancer: a systematic review. European Urology 2011 59 5 671 681 2-s2.0-79953249325 10.1016/j.eururo.2011.01. 044
20. Lawrie C. H., Gal S., Dunlop H. M., Pushkaran B., Liggins A. P., Pulford K., Banham A. H., Pezzella F., Boultwood J., Wainscoat J. S., Hatton C. S. R., Harris A. L., Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British Journal of Haematology 2008 141 5 672 675 2-s2.0-43449102192 10.1111/j.1365-2141.2008. 07077.x
21. Kosaka N., Iguchi H., Ochiya T., Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Science 2010 101 10 2087 2092 2-s2.0-77957091969 10.1111/j.1349-7006.2010.01650.x
22. Szafranska A. E., Davison T. S., John J., Cannon T., Sipos B., Maghnouj A., Labourier E., Hahn S. A., MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007 26 30 4442 4452 2-s2.0-34248200155 10.1038/sj.onc.1210228
23. Lebanony D., Benjamin H., Gilad S., Ezagouri M., Dov A., Ashkenazi K., Gefen N., Izraeli S., Rechavi G., Pass H., Nonaka D., Li J., Spector Y., Rosenfeld N., Chajut A., Cohen D., Mansukhani M., Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. Journal of Clinical Oncology 2009 27 12 2030 2037 2-s2.0-65349166324 10.1200/JCO.2008.19.4134
24. Benjamin H., Lebanony D., Cohen L., Differential diagnosis of mesothelioma using a microRNA assay. Proceedings of the 44th American Society of Clinical Oncology Annual Meeting June 2008 Chicago, Ill, USA. Abstract 22000
25. Rosenfeld N., Aharonov R., Meiri E., Rosenwald S., Spector Y., Zepeniuk M., Benjamin H., Shabes N., Tabak S., Levy A., Lebanony D., Goren Y., Silberschein E., Targan N., Ben-Ari A., Gilad S., Sion-Vardy N., Tobar A., Feinmesser M., Kharenko O., Nativ O., Nass D., Perelman M., Yosepovich A., Shalmon B., Polak-Charcon S., Fridman E., Avniel A., Bentwich I., Bentwich Z., Cohen D., Chajut A., Barshack I., microRNAs accurately identify cancer tissue origin. Nature Biotechnology 2008 26 4 462 469 2-s2.0-41849114566 10.1038/nbt1392
26. Sheedy F. J., O'Neill L. A. J., Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Annals of the Rheumatic Diseases 2008 67 supplement 3 iii50 iii55 2-s2.0-56749185827 10.1136/ard.2008.100289
27. Zhu S., Si M., Wu H., Mo Y., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). Journal of Biological Chemistry 2007 282 19 14328 14336 2-s2.0-34347266556 10.1074/jbc.M611393200
28. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S. T., Patel T., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007 133 2 647 658 2-s2.0-34547524771 10.1053/j.gastro.2007.05.022
29. Zhang Z., Li Z., Gao C., Chen P., Chen J., Liu W., Xiao S., Lu H., miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory Investigation 2008 88 12 1358 1366 2-s2.0-56649120601 10.1038/labinvest.2008.94
30. Wang B., Zhang Q., The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. Journal of Cancer Research and Clinical Oncology 2012 138 10 1659 1666 10.1007/s00432-012-1244-9
31. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M. L., Bayless T. M., Brant S. R., Chakravarti S., Kwon J. H., microRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008 135 5 1435 1438 2-s2.0-55249119513 10.1053/j.gastro.2008.07.068
32. Gantier M. P., Sadler A. J., Williams B. R. G., Fine-tuning of the innate immune response by microRNAs. Immunology and Cell Biology 2007 85 6 458 462 2-s2.0-34548458193 10.1038/sj.icb.7100091
33. O'Connell R. M., Rao D. S., Chaudhuri A. A., Baltimore D., Physiological and pathological roles for microRNAs in the immune system. Nature Reviews Immunology 2010 10 2 111 122 2-s2.0-75649139134 10.1038/nri2708
34. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008 18 10 997 1006 2-s2.0-53349177819 10.1038/cr.2008.282
35. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers. Nature 2005 435 7043 834 838 2-s2.0-20444460289 10.1038/nature03702
36. Mateescu B., Batista L., Cardon M., Gruosso T., De Feraudy Y., Mariani O., Nicolas A., Meyniel J., Cottu P., Sastre-Garau X., Mechta-Grigoriou F., MiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nature Medicine 2011 17 12 1627 1635 2-s2.0-84856111309 10.1038/nm.2512
37. Brase J. C., Johannes M., Schlomm T., Haese A., Steuber T., Beissbarth T., Kuner R., Sültmann H., Circulating miRNAs are correlated with tumor progression in prostate cancer. International Journal of Cancer 2011 128 3 608 616 2-s2.0-78649837502 10.1002/ijc.25376
38. Selth L. A., Townley S., Gillis J. L., Ochnik A. M., Murti K., Macfarlane R. J., Chi K. N., Marshall V. R., Tilley W. D., Butler L. M., Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. International Journal of Cancer 2012 131 3 652 661 10.1002/ijc.26405
39. Bryant R. J., Pawlowski T., Catto J. W. F., Marsden G., Vessella R. L., Rhees B., Kuslich C., Visakorpi T., Hamdy F. C., Changes in circulating microRNA levels associated with prostate cancer. British Journal of Cancer 2012 106 4 768 774 2-s2.0-84856812332 10.1038/bjc.2011.595
40. Nguyen H. C., Xie W., Yang M., Hsieh C. L., Drouin S., Lee G. S., Kantoff P. W., Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. The Prostate 2013 73 4 346 354 10.1002/pros.22572
41. Agaoglu F. Y., Kovancilar M., Dizdar Y., Darendeliler E., Holdenrieder S., Dalay N., Gezer U., Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumor Biology 2011 32 3 583 588 2-s2.0-79960571788 10.1007/s13277-011-0154-9
42. Mahn R., Heukamp L. C., Rogenhofer S., Von Ruecker A., Müller S. C., Ellinger J., Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011 77 5 1265 e16 2-s2.0-79955630404 10.1016/j.urology.2011.01. 020
43. Meng F., Henson R., Lang M., Wehbe H., Maheshwari S., Mendell J. T., Jiang J., Schmittgen T. D., Patel T., Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006 130 7 2113 2129 2-s2.0-33744521896 10.1053/j.gastro.2006. 02.057
44. Blower P. E., Chung J., Verducci J. S., Lin S., Park J., Dai Z., Liu C., Schmittgen T. D., Reinhold W. C., Croce C. M., Weinstein J. N., Sadee W., microRNAs modulate the chemosensitivity of tumor cells. Molecular Cancer Therapeutics 2008 7 1 1 9 2-s2.0-38349190243 10.1158/1535-7163.MCT-07-0573
45. Watahiki A., Macfarlane R. J., Gleave M. E., Crea F., Wang Y., Helgason C. D., Chi K. N., Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer. International Journal of Molecular Sciences 2013 14 4 7757 7770 10.3390/ijms14047757
46. Folini M., Gandellini P., Longoni N., Profumo V., Callari M., Pennati M., Colecchia M., Supino R., Veneroni S., Salvioni R., Valdagni R., Daidone M. G., Zaffaroni N., miR-21: an oncomir on strike in prostate cancer. Molecular Cancer 2010 9 12 2-s2.0-76949085030 10.1186/1476-4598-9-12
47. Konishi H., Ichikawa D., Komatsu S., Shiozaki A., Tsujiura M., Takeshita H., Morimura R., Nagata H., Arita T., Kawaguchi T., Hirashima S., Fujiwara H., Okamoto K., Otsuji E., Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. British Journal of Cancer 2012 106 4 740 747 2-s2.0-84857037689 10.1038/bjc.2011.588